MetaCap

Nanobiotix S.A. (NBTX) vs Phibro Animal Health (PAHC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Nanobiotix S.A. (NBTX) has outperformed Phibro Animal Health (PAHC) over the past year, gaining 26.6% versus a loss of 20.0%. Over five years, NBTX leads with a +214.0% price change compared with +59.4% for PAHC. Phibro Animal Health is the larger company by market cap ($1.35 billion vs $1.35 billion), about 1.0 times the size.

Phibro Animal Health pays a dividend yielding 1.44%, while Nanobiotix S.A. does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NBTX+26.61%PAHC-20.03%
+173%+66%-41%
Nov 21, 20251 yearNov 20, 2026
NBTX+185.87%PAHC+52.78%
+482%+189%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NBTX versus PAHC key metrics
MetricNBTXPAHC
Share price$26.50$33.29
Market cap$1.35B$1.35B
1-day change-2.98%-2.32%
YTD return+14.62%-10.89%
1-year return+26.61%-20.03%
5-year return+213.98%+59.43%
P/E ratio (TTM)—13.26
Forward P/E—8.58
EPS (TTM)$-1.27$2.51
Dividend yield0.00%1.44%
Annual dividend$0.00$0.48
Revenue (latest FY)—$1.52B
Revenue growth (YoY)—+17.12%
Net income (latest FY)—$99.72M
Gross margin—33.76%
Operating margin—12.81%
Net margin—6.57%
52-week high$57.14$60.08
52-week low$19.14$28.25
Distance from 52-week high-53.62%-44.59%
Analyst consensusnonehold
Avg. price target upside+101.06%+41.18%
Average volume148.94K228.99K
Shares outstanding50.95M21.11M
Employees982,605
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NBTX has outperformed PAHC by 46.6 percentage points over the past year.
  • Phibro Animal Health offers a meaningfully higher dividend yield (1.44% vs 0.00%).

About Nanobiotix S.A.

NBTX stock →

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Health Care · Biotechnology: Pharmaceutical Preparations · 98 employees

About Phibro Animal Health

PAHC stock →

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.

Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees

NBTX vs PAHC FAQ

Which is bigger, Nanobiotix S.A. or Phibro Animal Health?

Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.35B compared with $1.35B for Nanobiotix S.A. (NBTX).

Which stock has performed better over the past year, NBTX or PAHC?

NBTX returned +26.61% over the past 12 months, compared with -20.03% for PAHC (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Nanobiotix S.A. or Phibro Animal Health?

Phibro Animal Health pays a dividend yielding 1.44%, while Nanobiotix S.A. does not currently pay a regular dividend.

Are Nanobiotix S.A. and Phibro Animal Health in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons